SCHEDULING STATUS
S3
Product Name
XEFO® 8 IV/IM
Active Ingredient
Lornoxicam
Sugar Information
XEFO contains sugar: 100,0 mg/vial mannitol.
Read Before You Receive XEFO
Read this information carefully before you receive XEFO.
Keep this information because you may need to read it again. If you have further questions, ask your doctor, pharmacist, nurse or other healthcare provider.
What Is in This Article
- What XEFO is and what it is used for
- What you need to know before you receive XEFO
- How to receive XEFO
- Possible side effects
- How to store XEFO
- Contents of the pack and other information
1. What XEFO Is and What It Is Used For
XEFO is a non-steroidal anti-inflammatory drug, also called an NSAID, and belongs to the oxicam class.
XEFO is used for the treatment of short-term mild to moderate pain when oral administration is inappropriate.
2. What You Need to Know Before You Receive XEFO
XEFO Should Not Be Administered to You
XEFO should not be administered if any of the following apply:
| XEFO should not be administered if | Details |
|---|---|
| You are allergic to lornoxicam | This includes allergy to the active ingredient |
| You are allergic to any other ingredient in XEFO | See the contents section |
| You are allergic to other NSAIDs | This includes acetylsalicylic acid |
| You suffer from hypovolemia or dehydration | XEFO should not be used |
| You suffer from gastro-intestinal bleeding | XEFO should not be used |
| You suffer from cerebrovascular bleeding | XEFO should not be used |
| You have other bleeding disorders | XEFO should not be used |
| You have a history of gastrointestinal bleeding, ulceration or perforation related to previous NSAID therapy | XEFO should not be used |
| You have an active or recurrent peptic ulcer | XEFO should not be used |
| You suffer from severe liver impairment | XEFO should not be used |
| You suffer from severe renal impairment | XEFO should not be used |
| You suffer from thrombocytopenia | XEFO should not be used |
| You suffer from severe heart failure | XEFO should not be used |
| You are pregnant or breastfeeding | XEFO should not be used |
| You are under 18 years old | XEFO is contraindicated |
| You are elderly, above 65 years | XEFO should not be used |
Warnings and Precautions
Tell your doctor or healthcare provider before being given XEFO if any of the following apply:
| Situation requiring medical advice |
|---|
| You have impaired kidney function |
| You have impaired liver function |
| You have recently had an operation |
| You have a history of hypertension |
| You have a history of heart failure |
| You suffer from gastric ulcers |
| You suffer from gastric bleeding |
| You are taking medicines that may cause gastric ulcers or gastric bleeding |
| You suffer from gastric diseases such as ulcerative colitis or Crohn’s disease |
| You have a history of bleeding tendency |
| You have a blood coagulation disorder |
| You have liver cirrhosis |
| You will be treated with XEFO for more than 3 months |
| You are going to be treated with heparin |
| You are going to be treated with tacrolimus |
Your doctor may monitor you with laboratory tests if you have a blood coagulation disorder, impaired liver function, liver cirrhosis, are elderly, or will be treated with XEFO for more than 3 months.
XEFO should not be used together with other NSAIDs such as acetylsalicylic acid, ibuprofen or COX-2 inhibitors. Ask your doctor or pharmacist if you are unsure.
Stop taking XEFO and contact your doctor immediately if you experience unusual abdominal symptoms such as abdominal bleeding, skin rash, mucosal lesions or other signs of hypersensitivity.
Medicines such as XEFO may be associated with a small increased risk of heart attack or stroke. The risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment.
If you have heart problems, previous stroke, or think you may be at risk of these conditions, discuss treatment with your doctor or pharmacist. Risk factors may include high blood pressure, diabetes, high cholesterol or smoking.
Children and Adolescents
XEFO is contraindicated in children under the age of 18 years.
Other Medicines and XEFO
Always tell your healthcare provider if you are taking any other medicines, including complementary or traditional medicines.
Particular care is needed if you are receiving any of the following:
| Medicine or medicine group |
|---|
| Cimetidine |
| Digoxin |
| Anticoagulants such as heparin, warfarin or phenprocoumon |
| Corticosteroids |
| Methotrexate |
| Lithium |
| Immunosuppressive agents such as cyclosporine or tacrolimus |
| Heart medicines such as digoxin, ACE-inhibitors or beta-adrenergic blockers |
| Diuretics |
| Quinolone antibiotics |
| Anti-platelet agents |
| NSAIDs such as aspirin, ibuprofen or acetylsalicylic acid |
| SSRI medicines |
| Sulphonylureas such as glibenclamide |
| Inducers and inhibitors of CYP2C9 isoenzymes |
XEFO With Food, Drink and Alcohol
Not applicable.
Pregnancy, Breastfeeding and Fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, consult your doctor, pharmacist or other healthcare provider before taking this medicine.
XEFO must not be taken if you are pregnant or breastfeeding.
The use of XEFO may impair fertility and is not recommended in women attempting to fall pregnant.
In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of XEFO should be considered.
Driving and Using Machines
It is not always possible to predict how much XEFO may interfere with daily activities.
Patients should avoid driving, operating machinery or performing hazardous tasks until they know how XEFO affects them.
Patients who experience dizziness or sleepiness during treatment with XEFO should refrain from driving or operating machinery.
3. How to Receive XEFO
Do not share medicines prescribed for you with any other person.
Recommended Dose
| Patient group | Dose |
|---|---|
| Adults | 8 mg I.V. or I.M. |
| Maximum daily dose | 16 mg |
| Additional dose | Some patients may need a further 8 mg within the first day of treatment |
Your doctor will tell you how long your treatment with XEFO will last.
If you feel that the effect of XEFO is too strong or too weak, tell your doctor or pharmacist.
You will not be expected to give yourself XEFO. It will be given by a person qualified to do so.
If You Receive More XEFO Than You Should
Since a healthcare provider will administer XEFO, the dosage will be controlled.
In the event of overdosage, your doctor will manage the overdose.
Contact your doctor or pharmacist if you have received more XEFO than prescribed.
Possible overdose symptoms may include:
| Possible overdose symptoms |
|---|
| Nausea |
| Vomiting |
| Cerebral symptoms |
| Dizziness |
| Disturbances in vision |
If You Forget to Receive XEFO
Since a healthcare provider will administer XEFO, it is unlikely that a dose will be missed.
If you have further questions on the use of this product, ask your doctor or pharmacist.
4. Possible Side Effects
XEFO can have side effects.
Not all side effects reported for XEFO are included here. If your general health worsens or if you experience any untoward effects while taking XEFO, consult your healthcare provider for advice.
Medicines such as XEFO may be associated with a small increased risk of heart attack or stroke.
The most common side effects of XEFO include nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea.
Side Effects Table
| Side-effect category | Side effects |
|---|---|
| Frequent side effects | Mild and transient headache, dizziness, nausea, abdominal pain, dyspepsia, diarrhoea, vomiting |
| Less frequent side effects | Pharyngitis, anaemia, thrombocytopenia, leukopenia, hypersensitivity, confusion, nervousness, agitation, somnolence, paraesthesia, dysgeusia, tremor, migraine, visual disturbances, hypertension, hot flush, haemorrhage, haematoma, dyspnoea, cough, melaena, haematemesis, stomatitis, oesophagitis, gastrooesophageal reflux, dysphagia, aphthous stomatitis, glossitis, hepatic function abnormal, dermatitis, bone pain, muscle spasms, myalgia, nocturia, micturition disorders, asthenia, prolonged bleeding time, purpura, bronchospasm, increased blood urea nitrogen and creatinine levels, perforated peptic ulcer |
| Less frequent side effects | Anorexia, insomnia, depression, conjunctivitis, vertigo, tinnitus, palpitations, tachycardia, flushing, constipation, flatulence, eructation, dry mouth, gastritis, gastric ulcer, upper abdominal pain, duodenal ulcer, mouth ulceration, increased liver function tests, SGPT/ALT or SGOT/AST increases, rash, pruritus, hyperhidrosis, erythematous rash, urticaria, alopecia, arthralgia, malaise, face oedema, weight changes, oedema, rhinitis |
| Serious less frequent side effects | Hepatocellular damage, ecchymosis, oedema and bullous reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis |
| Side effects not listed | Any side effect not mentioned or any unexpected health change should be reported to your doctor or pharmacist |
Reporting of Side Effects
If side effects occur, speak to your doctor, pharmacist or nurse.
Side effects may also be reported to SAHPRA through the Med Safety App and eReporting platform.
Side effects may also be reported to Acino Pharma.
Reporting side effects helps provide more information on the safety of XEFO.
5. How to Store XEFO
Store all medicines out of reach of children.
Return all unused medicine to your pharmacist.
Do not dispose of unused medicine in drains or sewerage systems.
Keep out of the reach and sight of children.
Store at room temperature at or below 25 ºC.
Keep the vial in the outer carton.
6. Contents of the Pack and Other Information
What XEFO Contains
The vial contains the active substance lornoxicam.
| Item | Content |
|---|---|
| One vial with powder | Contains 8 mg lornoxicam |
| Reconstituted solution | One ml contains 4 mg lornoxicam |
| Other ingredients | Mannitol, trometamol, disodium edetate |
What XEFO Looks Like and Contents of the Pack
XEFO 8 IV/IM is a freeze-dried powder in an amber-coloured glass vial.
XEFO Water for Injection is a clear, colourless liquid in a clear glass ampoule.
When reconstituted, the medicine is a yellow, clear liquid free of visible particles.
The pack may contain:
| Pack contents |
|---|
| A vial containing freeze-dried powder and a 2 ml glass ampoule with Water for Injection packed as a set in one pack |
| A vial containing freeze-dried powder only |
Package Sizes Available
| Package size |
|---|
| 1 set |
| 5 sets |
| Vial only: 5 vials per pack |
Not all pack sizes may be marketed.
Holder of Certificate of Registration
Acino Pharma (Pty) Ltd
106 16th Road
Midrand
This Leaflet Was Revised In
31 October 2024
Registration Number
| Product | Registration number |
|---|---|
| XEFO 8 IV/IM | 33/3.1/0249 |
| XEFO Water for Injection | 33/34/0250 |
Registration No.
| Country | Registration information |
|---|---|
| Namibia | NS2: 04/3.1/0752 |
Medical Disclaimer
This article is intended as patient information based on the approved leaflet structure. It does not replace advice from a doctor, pharmacist, nurse or other healthcare provider. For regulated medical product use, follow the approved patient information leaflet and healthcare professional guidance.





